CTX-944

N/A

Report date: 2025/01/26 18:21:15
NME

Base Information

Drug NameCTX-944
Drug Alias Namemicrobiome-based therapy (ConsortiaTX)CTX-944
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMicrobiome modulators
TargetsUpdating
Therapy Area/IndicationsFood Hypersensitivity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesThe Brigham and Women's Hospital
China Registration ClassN/A

Develop Information

Active CompaniesConsortia TX Inc
Inactive CompaniesN/A
Active IndicationsFood Hypersensitivity
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A